Seamus Fernandez
Stock Analyst at Guggenheim
(4.96)
# 107
Out of 4,673 analysts
424
Total ratings
65.4%
Success rate
32.7%
Average return
Main Sectors:
Stocks Rated by Seamus Fernandez
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals | Maintained: Buy | $40 → $55 | $35.11 | +56.65% | 10 | Aug 19, 2026 | |
| MLYS Mineralys Therapeutics | Reiterated: Buy | $48 → $52 | $26.61 | +95.42% | 9 | Aug 12, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $25 | $10.58 | +136.29% | 5 | Aug 12, 2026 | |
| TENX Tenax Therapeutics | Maintained: Buy | $40 → $4 | $1.70 | +135.29% | 7 | Aug 11, 2026 | |
| SEPN Septerna | Reiterated: Buy | $45 → $51 | $43.80 | +16.44% | 3 | Aug 11, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Maintained: Hold | n/a | $8.21 | - | 11 | Aug 6, 2026 | |
| ARQT Arcutis Biotherapeutics | Rated: Buy | $35 → $38 | $26.54 | +43.18% | 15 | Aug 5, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | $116 | $59.79 | +94.01% | 14 | Aug 5, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $143 | $115.25 | +24.08% | 14 | Aug 4, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Buy | $72 → $75 | $66.05 | +13.55% | 50 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 | $66.52 | +32.29% | 15 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,235 → $1,273 | $1,225.73 | +3.86% | 62 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $44.97 | - | 13 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 16,500p → 16,200p | 11,806p | +37.22% | 20 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $16.08 | +86.57% | 3 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $134.57 | - | 12 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.64 | +137.07% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $6.31 | +90.33% | 4 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $53.53 | +161.54% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €110.00 → €101.00 | €77.67 | +30.04% | 10 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $45.71 | n/a | 10 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.97 | n/a | 12 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 1,013 → kr 798.00 | kr 289.45 | n/a | 4 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $51.15 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1,888.00 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $130 | $135.17 | n/a | 36 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $83 | $25.57 | n/a | 5 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.8681 | n/a | 2 | Dec 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $136.75 | n/a | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $125.56 | n/a | 4 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $154.55 | n/a | 16 | Oct 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $3.92 | n/a | 1 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.20 | n/a | 2 | Sep 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 | $27.25 | n/a | 16 | Sep 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 | $14.01 | n/a | 1 | Aug 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $7.01 | n/a | 3 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $228.61 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $425.28 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $810.24 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $271.11 | n/a | 2 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 | $34.40 | n/a | 5 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $41.79 | n/a | 1 | Mar 7, 2016 |
Amylyx Pharmaceuticals
Aug 19, 2026
Maintained: Buy
Price Target: $40 → $55
Current: $35.11
Upside: +56.65%
Mineralys Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $48 → $52
Current: $26.61
Upside: +95.42%
Sagimet Biosciences
Aug 12, 2026
Reiterated: Buy
Price Target: $25
Current: $10.58
Upside: +136.29%
Tenax Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $40 → $4
Current: $1.70
Upside: +135.29%
Septerna
Aug 11, 2026
Reiterated: Buy
Price Target: $45 → $51
Current: $43.80
Upside: +16.44%
Arcturus Therapeutics Holdings
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $8.21
Upside: -
Arcutis Biotherapeutics
Aug 5, 2026
Rated: Buy
Price Target: $35 → $38
Current: $26.54
Upside: +43.18%
Vaxcyte
Aug 5, 2026
Reiterated: Buy
Price Target: $116
Current: $59.79
Upside: +94.01%
Rhythm Pharmaceuticals
Aug 4, 2026
Reiterated: Buy
Price Target: $143
Current: $115.25
Upside: +24.08%
Bristol-Myers Squibb Company
Jul 31, 2026
Reiterated: Buy
Price Target: $72 → $75
Current: $66.05
Upside: +13.55%
Jul 14, 2026
Reiterated: Buy
Price Target: $88
Current: $66.52
Upside: +32.29%
Jul 13, 2026
Rated: Buy
Price Target: $1,235 → $1,273
Current: $1,225.73
Upside: +3.86%
Jul 9, 2026
Maintained: Hold
Price Target: n/a
Current: $44.97
Upside: -
Jul 9, 2026
Reiterated: Buy
Price Target: 16,500p → 16,200p
Current: 11,806p
Upside: +37.22%
Jun 24, 2026
Reiterated: Buy
Price Target: $30
Current: $16.08
Upside: +86.57%
Jun 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $134.57
Upside: -
May 27, 2026
Reiterated: Buy
Price Target: $11
Current: $4.64
Upside: +137.07%
May 11, 2026
Reiterated: Buy
Price Target: $12
Current: $6.31
Upside: +90.33%
May 7, 2026
Maintained: Buy
Price Target: $140
Current: $53.53
Upside: +161.54%
Oct 8, 2025
Maintained: Buy
Price Target: €110.00 → €101.00
Current: €77.67
Upside: +30.04%
Apr 17, 2025
Downgraded: Hold
Price Target: n/a
Current: $45.71
Upside: n/a
Apr 3, 2025
Rated: Hold
Price Target: n/a
Current: $2.97
Upside: n/a
Jan 17, 2025
Maintained: Buy
Price Target: kr 1,013 → kr 798.00
Current: kr 289.45
Upside: n/a
Oct 31, 2024
Downgraded: Hold
Price Target: n/a
Current: $51.15
Upside: n/a
Oct 31, 2024
Downgraded: Hold
Price Target: n/a
Current: $1,888.00
Upside: n/a
Jan 29, 2024
Maintained: Buy
Price Target: $125 → $130
Current: $135.17
Upside: n/a
Oct 14, 2022
Maintained: Buy
Price Target: $250 → $83
Current: $25.57
Upside: n/a
Dec 15, 2021
Downgraded: Hold
Price Target: n/a
Current: $0.8681
Upside: n/a
Dec 7, 2021
Downgraded: Hold
Price Target: n/a
Current: $136.75
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: n/a
Current: $125.56
Upside: n/a
Oct 8, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $154.55
Upside: n/a
Oct 17, 2017
Initiated Coverage: Buy
Price Target: $13
Current: $3.92
Upside: n/a
Sep 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $4.20
Upside: n/a
Sep 8, 2016
Maintained: Hold
Price Target: $37
Current: $27.25
Upside: n/a
Aug 24, 2016
Reiterated: Buy
Price Target: $108
Current: $14.01
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $52
Current: $7.01
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $228.61
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $425.28
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $810.24
Upside: n/a
Jun 14, 2016
Maintained: Buy
Price Target: $125
Current: $271.11
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $56
Current: $34.40
Upside: n/a
Mar 7, 2016
Downgraded: Hold
Price Target: $4
Current: $41.79
Upside: n/a